Alemtuzumab

Lemtrada 12 MG Concentrado Para Solucion Para Perfusion

10,0 mg concentrado para solución para perfusiónSpainMarketedAuthorised 19 Dec 2013

In other countries

The same active substances on other registers, the same brand first.

LemtradaCanada · 12 MG / 1.2 ML · Solution · Sanofi-Aventis Canada INCSame brand
LemtradaEuropean Union · Sanofi BelgiumSame brand
LemtradaCroatiaSame brand
LemtradaItaly · Concentrato per soluzione per infusione · Sanofi BelgiumSame brand
LEMTRADA 12 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Sanofi BelgiumSame brand
LemtradaRomania · 12mg/1.2ml · conc. pt. sol. perf. · Genzyme Therapeutics LTDSame brand
LEMTRADA 12mgRomania · 12mg/1,2ml · conc. pt. sol. perf. · Sanofi BelgiumSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Alemtuzumab

Lemtrada 12 MG Concentrado Para Solucion Para Perfusion

10,0 mg concentrado para solución para perfusiónSpainMarketedAuthorised 19 Dec 2013

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lemtrada®Serbia · 12mg/1.2mL · koncentrat za rastvor za infuziju · Amicus SRB D.O.O.

Lemtrada 12 MG Concentrate for Solution for InfusionSaudi Arabia · Boehringer Ingelheim Pharma GmbH & Co. KG

Lemtrada Concentrate for Solution for Infusion 12 MG/ 1.2 MLSingapore · 12 mg/1.2 ml · infusion, solution concentrate · Sanofi-Aventis Singapore Pte. LTD.

LemtradaUnited States · 12MG/1.2ML · injectable · Genzyme

CampathUnited States · 10MG/ML, 30MG/ML · vial · Genzyme

MabcampathCanada · 30 MG / ML · Solution · Sanofi-Aventis Canada INC

MabcampathCanada · 10 MG / ML · Solution · Genzyme Corporation

MabCampathEuropean Union · Genzyme Europe B.V.

Packs

Pack	Code	Status
LEMTRADA 12 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 1,2 ml	701018

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Alemtuzumab
Strength: 10,0 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 19 Dec 2013
Registration: 112869001
Marketing authorisation holder: Sanofi Belgium
Procedure: EU centralised
Supply: Uso Hospitalario